Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2660504 | 0.85 | AKR1B1 (0.45) | AKR1B1TAAR1SMN1; SMN2GAACYP1A2 | |
| SCHEMBL692568 | 0.85 | TSHR (0.52) | AKR1B1TAAR1SMN1; SMN2GAACYP1A2 | |
| SCHEMBL954701 | 0.83 | AKR1B1 (0.43) | AKR1B1TAAR1SMN1; SMN2GAACYP1A2 | |
| SCHEMBL1372359 | 0.83 | TSHR (0.48) | AKR1B1TAAR1SMN1; SMN2GAAGABRA1 | |
| SCHEMBL1007985 | 0.83 | AKR1B1 (0.43) | AKR1B1TAAR1SMN1; SMN2GAAGABRA1 | |
| SCHEMBL8478408 | 0.83 | AKR1B1 (0.43) | AKR1B1TAAR1SMN1; SMN2GAACYP1A2 | |
| SCHEMBL15569427 | 0.83 | AKR1B1 (0.43) | AKR1B1TAAR1SMN1; SMN2GAACYP1A2 | |
| SCHEMBL697704 | 0.83 | TAAR1 (0.67) | TAAR1SMN1; SMN2GAAKMT2AMAPT | |
| SCHEMBL29960244 | 0.83 | AKR1B1 (0.43) | AKR1B1TAAR1SMN1; SMN2GAACYP1A2 | |
| SCHEMBL28415698 | 0.81 | NOTUM (0.42) | AKR1B1TAAR1SMN1; SMN2GAACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 727 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559582-B2 | Polyacrylate polymer | BASF SE (DE) | 2026-02-24 | — | — | US | claimed |
| US-20250382412-A1 | PROCESS FOR THE SYNTHESIS OF POLY-4-HYDROXYBUTYRATE | BASF SE (DE) | 2025-12-18 | — | — | US | claimed |
| EP-4547731-A1 | PROCESS FOR THE SYNTHESIS OF POLY-4-HYDROXYBUTYRATE | BASF SE (DE) | 2025-05-07 | — | — | EP | claimed |
| CN-119452014-A | Method for synthesizing poly-4-hydroxybutyrate | 巴斯夫欧洲公司 | 2025-02-14 | — | — | CN | claimed |
| WO-2024003243-A1 | PROCESS FOR THE SYNTHESIS OF POLY-4-HYDROXYBUTYRATE | BASF SE (DE) | 2024-01-04 | — | — | WO | claimed |
| CN-115286491-B | Preparation method of 2- [2- (6-bromohexyloxy) ethoxymethyl ] -1, 3-dichlorobenzene | 山东省药学科学院 | 2023-09-15 | — | — | CN | claimed |
| CN-115286491-A | Preparation method of 2- [2- (6-bromohexyloxy) ethoxymethyl ] -1,3-dichlorobenzene | 山东省药学科学院 | 2022-11-04 | — | — | CN | claimed |
| EP-4013398-A1 | AN IMPROVED PROCESS FOR PREPARATION OF VILANTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Melody Healthcare Pvt. Ltd. (IN) | 2022-06-22 | — | — | EP | claimed |
| EP-3898730-A1 | POLYACRYLATE POLYMER | BASF SE (DE) | 2021-10-27 | — | — | EP | claimed |
| CN-113195564-A | Polyacrylate polymers | 巴斯夫欧洲公司 | 2021-07-30 | — | — | CN | claimed |
| WO-2007134107-A2 | COLD MENTHOL RECEPTOR-1 ANTAGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-11-22 | — | — | WO | claimed |
| EP-1513843-B1 | PYRAZOLOPYRIMIDINES AND THE USE THEREOF FOR CONTROLLING HARMFUL ORGANISMS | BAYER CROPSCIENCE AG (DE) | 2007-07-04 | — | — | EP | claimed |
| US-7186831-B2 | 5-halo-2-alkyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amines | BAYER CROPSCIENCE LP (DE) | 2007-03-06 | — | — | US | claimed |
| EP-1392693-B1 | TRIAZOLOPYRIMIDINES FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2007-02-07 | — | — | EP | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-6620823-B2 | Antiinflammatory agents; rheumatic disorders | BRISTOL-MYERS SQUIBB PHARME COMPANY | 2003-09-16 | — | — | US | claimed |
| EP-0272674-B1 | PROCESS FOR PRODUCING 2,6-DICHLOROBENZYL ALCOHOL | HODOGAYA CHEMICAL CO., LTD. (JP) | 1993-03-17 | — | — | EP | claimed |
| US-4822924-A | REACTING 2,6-DICHLOROBENZYL CHLORIDE WITH SODIUM ACETATE, THEN HYDROLYZING; QUATERNARY AMMONIUM SALTS AS PHASE TRANSFER AGENTS | HODOGAYA CHEMICAL CO., LTD. (JP) | 1989-04-18 | — | — | US | claimed |
| EP-0272674-A2 | Process for producing 2,6-dichlorobenzyl alcohol | HODOGAYA CHEMICAL CO., LTD. (JP) | 1988-06-29 | — | — | EP | claimed |
| US-4167583-A | A DICHLOROBENZYL ALCOHOL AND PROPYL ALCOHOL; TOPICAL ANTISEPTIC | BAYER AKTIENGESELLSCHAFT (DE) | 1979-09-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559582-B2 | Polyacrylate polymer | SAAL1, ATXN2L, VCL | AKR1B1 1525/4885TAAR1 1915/4885SMN1; SMN2 1269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.